1230.1000 7.90 (0.65%)
NSE May 23, 2025 15:31 PM
Volume: 734.3K
 

1230.10
0.65%
ICICI Securities Limited
Q3FY19 results were higher than I-direct estimates on profitability front while revenues were lower mainly due to lower US sales. Revenues were muted at | 3864.6 crore (I-direct estimate: | 4015 crore). Growth of 10% in domestic market to | 674.1 crore (I-direct estimate: | 674 crore) and 25.0% YoY growth in Russia & CIS to | 550 crore (I-direct estimate: | 550 crore) were largely offset by 7.7% fall in US sales to | 1483.2 crore (I-direct estimate: | 1600 crore) EBITDA margins remained at 20.8% YoY but came in 212 bps higher...
Number of FII/FPI investors decreased from 927 to 911 in Mar 2025 qtr
More from Dr. Reddy's Laboratories Ltd.
Recommended